Xos, Inc. Announces \$6 Million Registered Direct Offering and Strategic Financing Agreements
Key Highlights
- Xos, Inc. (Nasdaq: XOS) entered into a Securities Purchase Agreement and a Placement Agency Agreement on June 4, 2026, for a registered direct offering of its common shares.
- Offering Details: The Company will sell 1,090,910 shares of common stock at \$5.50 per share, raising gross proceeds of approximately \$6 million.
- Placement Agent: Roth Capital Partners, LLC acted as the exclusive placement agent and will receive a cash fee of 6.5% of the gross proceeds and reimbursement of certain expenses up to \$75,000.
- Use of Proceeds: The Company will use the net proceeds as described in the Prospectus Supplement, specifics of which should be reviewed by investors for insight into company strategy and liquidity impacts.
- Legal Opinion: An opinion from Proskauer Rose LLP regarding the legality of the shares was filed as an exhibit, affirming the validity of the issuance.
Details of the Financing Agreements
Under the terms of the Placement Agency Agreement, Xos, Inc. has committed to pay Roth Capital Partners, LLC a cash fee equal to 6.5% of the total gross proceeds from the offering, in addition to reimbursing placement-related expenses up to \$75,000. These agreements include standard indemnification and representation clauses, offering investors additional transparency and assurance regarding the integrity of the transaction.
The purchase price per share for investors is set at \$5.50, and the offering is being conducted directly with selected institutional investors. The Placement Agent may engage other broker-dealers as sub-agents or selected dealers, which could help increase the distribution of the shares among professional investors.
Implications for Shareholders
- Dilution of Existing Shareholders: This offering will increase the outstanding shares of Xos, Inc., which will dilute the holdings of current shareholders. Investors should assess the impact of this dilution relative to the anticipated benefits of the capital raise.
- Restriction on Further Issuances: For 30 days after the closing date, Xos and its subsidiaries are restricted from issuing or announcing new shares or equivalent securities, or filing additional registration statements, except for certain exempt issuances and “at-the-market” offerings. This lock-up period is intended to provide market stability and reassure investors that the company will not quickly dilute the share base further.
- Nasdaq Compliance and Listing: The Company is committed to maintaining the listing of its common stock on the Nasdaq Capital Market and will file a listing of additional shares notification with Nasdaq in connection with this offering. This is crucial for liquidity and investor confidence.
- Reverse Stock Split Restriction: For 12 months after closing, Xos cannot undertake a reverse stock split or reclassification of its common stock without the prior written consent of investors holding a majority of shares from this offering, unless required to maintain Nasdaq listing.
- No Material Adverse Change: As a closing condition, there must not have occurred any material adverse change in the company’s business, financial condition, or prospects, increasing transparency and investor protection.
- Financial Controls and Reporting: Xos represents that it has timely filed all required reports with the SEC, and its financial statements are compliant with GAAP and SEC regulations, supporting transparency and governance.
- Legal Proceedings: There are no significant undisclosed legal actions, proceedings, or investigations against Xos, Inc. that could materially impact its operations, as confirmed by the company’s representations.
- No Registration Rights Granted: No person has any right to cause the company or any subsidiary to effect the registration under the Securities Act of any securities, reducing the risk of unexpected future dilutive events.
- Restriction on Insider Information: The company covenants it will not provide material non-public information to investors unless they agree to keep it confidential, and will publicly disclose all material terms via press release and SEC filings.
Potential Price-Sensitive Elements
-
Capital Raise and Dilution:
The offering increases available capital for Xos, which may be used for growth initiatives, working capital, or other strategic purposes. The dilution from the new share issuance, however, may put downward pressure on the stock price in the short term. -
Lock-Up and Listing Commitments:
Restrictions on further issuance and a commitment to maintain Nasdaq listing could support the share price by reducing uncertainty and potential negative surprises in the near term. -
Reverse Split Restriction:
The prohibition on a reverse split, unless required for listing, may be positively viewed by shareholders but limits the company’s flexibility.
Other Noteworthy Details for Investors
- The company confirms it is not an investment company under the Investment Company Act of 1940 and will conduct business to avoid such a classification.
- No brokerage or finder’s fees are payable by the company other than those owed to the Placement Agent, and the purchasers have no obligations for such fees.
- The company has made extensive representations regarding the absence of undisclosed liabilities, compliance with all material contracts, and the absence of material adverse changes since the last SEC filing.
- The company has committed to using its best efforts to maintain eligibility of its common stock for electronic transfer through the Depository Trust Company.
- The Placement Agent and investors are expressly not acting as fiduciaries or financial advisors to the company.
- The company has not taken any action designed to manipulate or stabilize its stock price in connection with this offering.
Conclusion
This registered direct offering represents a significant development for Xos, Inc., providing the company with approximately \$6 million in gross proceeds. While the capital infusion may support growth and strategic initiatives, current shareholders should be aware of the dilution impact. The company’s commitments to transparency, SEC compliance, and Nasdaq listing, alongside restrictions on further dilution and reverse splits, are designed to protect investor interests in the near term. Investors are encouraged to review the Prospectus Supplement and related SEC filings for further details, especially regarding the intended use of proceeds and any potential impacts on future operations or valuation.
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investors should conduct their own due diligence and consult with their financial advisors before making investment decisions. The details herein are based on disclosures made by Xos, Inc. in its SEC filings and related agreements as of June 2026. Actual outcomes and future developments may differ materially from those discussed.
